IIM
DNTH icon

INTECH Investment Management’s Dianthus Therapeutics DNTH Stock Holding History

INTECH Investment Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$626K Buy
7,465
+1,464
+24% +$84.8K 0.01% 1234
2025
Q4 		$247K Buy
+6,001
New +$233K ﹤0.01% 1864
2025
Q3 		– Sell
-12,969
Closed -$242K – 2433
2025
Q2 		$242K Hold
12,969
– – ﹤0.01% 1992
2025
Q1 		$235K Buy
12,969
+3,726
+40% +$82.1K ﹤0.01% 2002
2024
Q4 		$201K Buy
+9,243
New +$238K ﹤0.01% 2026

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

INTECH Investment Management's DNTH Position: Q1 2026 in Review

INTECH Investment Management increased its Dianthus Therapeutics (DNTH) stake by 24% in Q1 2026, buying an estimated $84.8K and bringing the position to 7,465 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #1234.

INTECH Investment Management first reported a position in DNTH in Q4 2024 and has held it in 5 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • INTECH Investment Management held 7,465 shares of Dianthus Therapeutics worth $626K as of Q1 2026.
  • INTECH Investment Management bought 1,464 Dianthus Therapeutics shares in Q1 2026, an estimated $84.8K.
  • Dianthus Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1234 holding.
  • INTECH Investment Management first reported a position in Dianthus Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.